4.3 Article

Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds

期刊

MEDICINAL CHEMISTRY
卷 17, 期 7, 页码 750-765

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573406416666200519085626

关键词

benzothiazole; letrozole; anticancer activity; aromatase; docking; 1; 3; 4-thiadiazole; imidazo(2; 1-b)(1; 3; 4)thiadiazole

资金

  1. Board of Research in Nu-clear Science (BRNS) [35/14/25/2017BRNS/35240]
  2. Government of India

向作者/读者索取更多资源

This research focuses on the synthesis and anticancer activity testing of 1,3,4-thiadiazole and its derivatives with potential anticancer properties. Two compounds (4b and 5b) showed effective inhibition equivalent to Letrozole, indicating promising anticancer activity in these new classes of derivatives. Further research on the mechanism of action and pathway for discovering potent antitumor agents is necessary.
Background: A great array of nitrogen-containing heterocyclic rings were being extensively explored for their functional versatility in the field of medicine, especially in anticancer research. 1,3,4thiadiazole is one of such heterocyclic rings with promising anticancer activity against several cancer cell lines, inhibiting diverse biological targets. Introduction: The 1,3,4-thiadiazole, when equipped with other heterocyclic scaffolds, has displayed enhanced anticancer properties. The thiourea, benzothiazole, imidazo[2,1,b][1,3,4]-thiadiazoles are such potential scaffolds with promising anticancer activity. Methods: A new series of 5-substituted-1,3,4-thiadiazoles linked with phenyl thiourea, benzothiazole and 2,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives were synthesized and tested for invitro anticancer activity on various cancer cell lines. Results: The National Cancer Institute's preliminary anticancer screening results showed compounds 4b and 5b having potent antileukemic activity. Compound 4b selectively showed 32 percent lethality on Human Leukemia-60 cell line. The docking studies of the derivatives on aromatase enzyme (Protein Data Bank: 3S7S) have shown reversible interactions at the active site with good docking scores comparable to Letrozole and Exemestane. Furthermore, the selected derivatives were tested for anticancer activity on HeLa cell line based on the molecular docking studies. Conclusion: Compounds 4b and 5b showed effective inhibition equivalent to Letrozole. These preliminary biological screening studies have given positive anticancer activity for these new classes of derivatives. An additional research study like the mechanism of action of the anticancer activity of this new class of compounds is necessary. These groundwork studies illuminate a future pathway for research of this class of compounds enabling the discovery of potent antitumor agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据